Gabel, Jr. v. Saul

CourtDistrict Court, N.D. Illinois
DecidedSeptember 11, 2019
Docket1:18-cv-04794
StatusUnknown

This text of Gabel, Jr. v. Saul (Gabel, Jr. v. Saul) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gabel, Jr. v. Saul, (N.D. Ill. 2019).

Opinion

F OINR TTHHEE UNNOIRTTEHDE SRTNA TDEISST DRIISCTTR IOCFT I CLLOIUNROTIS EASTERN DIVISION

JAMES G., JR., ) ) Plaintiff, ) ) No. 18-cv-4794 v. ) ) Magistrate Judge Susan E. Cox ANDREW M. SAUL, Commissioner of the ) Social Security Administration1, ) ) Defendant. )

MEMORANDUM OPINION AND ORDER Plaintiff James G., Jr. (“Plaintiff”)2 appeals the decision of the Commissioner of the Social Security Administration (“Commissioner”) denying his disability insurance benefits under sections 216(i) and 223(d) of the Social Security Act through March 31, 2017, the last date insured. The Parties have filed cross motions for summary judgment. For the reasons detailed below, the Commissioner’s Motion for Summary Judgment (dkt. 23) is granted, Plaintiff’s motion (dkt. 12) is denied, and the Administrative Law Judge’s decision is affirmed. I. Background a. Factual Background and Procedural History Plaintiff alleges an inability to work due to pain in his lower back and legs resulting from two workplace injuries. (R. 195-99.) Although Plaintiff fully recovered from the first injury occurring in 2008 – which required in an L5-S1 fusion – he was reinjured in 2012. (R. 286, 361.) Plaintiff, a 35- year-old delivery truck driver for a beverage company, injured his back for the second time on January 4, 2012; while attempting to bounce a 250-pound handcart up a flight of stairs, Plaintiff felt a pop

1 As of June 4, 2019, Andrew M. Saul is the Commissioner of the Social Security Administration. Pursuant to Federal Rule Civil Procedure 25(d), he is hereby substituted as Defendant. 2 In accordance with Northern District of Illinois Internal Operating Procedure 22, the Court refers to Plaintiff only by with sharp pain to his lower back. (R. 459, 671.) After treatments of injections, pain medications, and physical therapy, Plaintiff’s treating physicians and physical therapists released him to light and medium work consistent with an FCE performed in 2013. (R. 295, 685.) However, State agency doctors recommended restricting Plaintiff to sedentary work while noting “subjective complaints of back pain” and that Plaintiff’s statements regarding the intensity, persistence, and limiting effects of the symptoms were not substantiated by the objective medical evidence alone. (R. 66, 70, 79.) In February of 2013, Dr. Daniel A. Troy deemed Plaintiff to have reached a medium-to-heavy physical demand level from a functional standpoint. (R. 337.) Several months later Frank Berardi OTR revealed Plaintiff’s ability to perform light to medium work, with several lifting and postural

restrictions including no lifting or carrying weight greater than 30 pounds on an occasional basis. (R. 355.) On May 7, 2013, Plaintiff reported chronic numbness in the left leg related to his previous back surgery performed in 2008. (R. 398-399.) In August 2014, orthopedic notes from Dr. Troy indicate Plaintiff was continuing to have chronic pain with radiation to his right leg. (R. 286) Imaging revealed degeneration of the lumbosacral discs consistent with status post L5-S1 fusion in 2008. (R. 287.) Gabapentin and Norco were prescribed for pain. (Id.) On November 4, 2014, Plaintiff reported an acute exacerbation of his chronic back pain. (R. 410.) On November 9, 2014, examination revealed tenderness from L1 to L5, limited range of

motion, decreased sensation over the lateral aspect of his bilateral legs, muscle spasm bilaterally in the paraspinous muscles, and a positive straight leg raising test. (R. 333-34.) Gabapentin and Norco were again prescribed, and Plaintiff was scheduled for an epidural injection. (Id.) 3 On November 20, 2014, an MRI and CT scan of Plaintiff’s lumbar spine revealed Grade 1 anteriolisthesis of L5 on S1 with postsurgical changes, moderate circumferential osteophytes resulting in mild to moderate

3 The injection was administered on February 8, 2015. (R. 339.) bilateral neuroforaminal narrowing, and mild degenerative changes elsewhere within the lumbar spine. (R. 342.) In December 2014, an orthopedic examination by Dr. Nicholas Angelopoulos noted a moderate antalgic gait and moderate limp while walking, muscle spasm bilaterally in the paraspinous muscles, restricted lumbar range of motion, 4/5 muscle strength in the lower left extremity, and a positive straight-leg raising test bilaterally. (R. 654.) During this examination, Plaintiff also revealed a history of a right knee ligament repair and a family history of osteoporosis. (R. 653.) In May of 2015, Plaintiff visited Dr. Alexander Ghanayem. (R. 672.) According to Dr. Ghanayem’s examination, Plaintiff had subjective complaints of bilateral leg pain in multiple nerve

distributions including L3, L4, L5, and S1 “in the context of a fusion that is radiographically stable at L5-S1, and no evidence of any adjacent level problems.” (Id.) Additionally, Dr. Ghanayem noted that “there is no objective structural loss of integrity in his lumber spine looking at the postoperative MRI scan” and that “the new onset of leg symptoms is not substantiated by objective testing.” (Id.) Dr. Ghanayem concluded his note recommending that Plaintiff “should return back to work at his pre-January 4, 2012 work status” and that “a brief course of physical therapy on the order of six to eight weeks would have been medically reasonable for the work injury as described.” (Id.) In July 2015, Plaintiff underwent a physical consultative examination with Dr. Kimberly Middleton, a family medicine practitioner. (R. 452-56.) The examination was based upon Dr.

Middleton’s brief examination and a review of Dr. Troy’s treatment notes from August 30, 2014. (R. 452.) Plaintiff presented with pain upon palpation along the paraspinal musculature bilaterally throughout the lumbar spine, spasms along the L4-S1 distribution, tenderness with palpation of the right S1 joint, and positive straight leg raising in both the sitting and supine position on the right. (R. 453-55.) He exhibited decreased tactile sensation along the “L5” distribution on the right, decreased tactile sensation along the left thigh, leg, and foot, and decreased flexion and pain with bilateral rotation and extension of the lumbar spine. (Id.) Treatment notes from June 2016 through May 2017 from Karuna Sachdeva, PA and Dr. Joel See, MD indicate that Plaintiff displayed a moderate antalgic gait, and that he had reported pain with forward flexion and extension of the lumbar spine and positive tenderness to palpation over the paraspinals. (R. 688, 694, 700, 704, 709, 714, 719.) On June 15, lumbar x-rays revealed mild bilateral perineural fibrosis involving the traversing bilateral S1 nerve roots and mild to moderate multilevel facet osteoarthritis of the mid to lower lumbar spine. (R. 729.) Plaintiff was seen eight times by his treating pain management physician, Dr. Joel See, from September 6, 2016 through May 30, 2017. (R. 692-736.) On October 7, 2016, Dr. See noted that the

MRI taken on June 15, 2016 showed no significant disc or facet abnormality, spinal stenuosis, or foraminal narrowing on L1-L2 or L2-L3, however there was mild to moderate bilateral facet arthropathy with ligamentum flavum thickening and facet hypertrophy from L4-L5 with no significant disc disease and no significant stenuosis. (R. 729.) In Plaintiff’s L5-S1, Dr. See notes evidence of a posterior hardware fusion with bilateral laminectomies and interbody fusion with a grade 1 anterolisthesis of approximately 6 millimeters with mild enhancing granulation tissue or fibrosis extending into the subarticular zones with suspicion for mild bilateral perineural fibrosis. (Id.)4 On November 7, 2016, Plaintiff reported “having functional improvement on the pain medications.” (R. 721.) On December 7, 2016, Plaintiff received ultrasound guided trigger point

injections with a solution containing “6 cc of 1% Lidocaine and 1 cc of Depo-Medrol 40 mg per mL + 60 mg Toradol.” (R. 719.) Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Gabel, Jr. v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gabel-jr-v-saul-ilnd-2019.